MEGAN ADLER: Open Payments
NPI 1346961307 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 56 payments from 12 companies in 2025. Trend: 2023 $735 · 2024 $1,247 · 2025 $1,112
Food & beverage: $1,027Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $401 |
| ABBVIE INC. | 11 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $174 |
| Celltrion USA Inc. | 6 | $112 |
| Phathom Pharmaceuticals, Inc. | 4 | $56 |
| Lilly USA, LLC | 1 | $33 |
| Ardelyx, Inc. | 2 | $31 |
| PFIZER INC. | 1 | $27 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
Products named: TREMFYA, ENTYVIO, VEGZELMA, RINVOQ, SKYRIZI, VOQUEZNA, OMVOH, IBSRELA.
Industry payments across TX — which companies pay providers there.
